Jiabing Wang
30Patents
7h-index
81Co-inventors
72Inventor score
Filing activity: May 3, 1996 → Aug 29, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6017926A | Integrin receptor antagonists | Chemistry; Metallurgy | 53 | Expired |
| US6048861A | Integrin receptor antagonists | Chemistry; Metallurgy | 43 | Expired |
| US7056909B2 | Alpha v integrin receptor antagonists | Chemistry; Metallurgy | 17 | Expired |
| US6472403B2 | &agr;V integrin receptor antagonists | Chemistry; Metallurgy | 12 | Expired |
| US6784190B2 | Integrin receptor antagonists | Chemistry; Metallurgy | 10 | Expired |
| US7268153B2 | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators | Chemistry; Metallurgy | 10 | Expired |
| US8008317B2 | Inhibitors of akt activtiy | Chemistry; Metallurgy | 7 | Active |
| US5900427A | N-heteroarenesulfonyl-protected amino acid reagents for peptide synthesis | Emerging Cross-Sectional Technologies | 4 | Expired |
| US8207169B2 | Substituted [1,2,4]triazolo[4′,3′:1,6]pyrido[2,3-b]pyrazines of the formula D | Human Necessities | 4 | Active |
| US8691825B2 | Inhibitors of AKT activity | Chemistry; Metallurgy | 3 | Active |
| US10822334B2 | ErbB receptor inhibitors | Chemistry; Metallurgy | 3 | Active |
| US9066979B2 | Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor | Chemistry; Metallurgy | 2 | Active |
| US9375432B2 | Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor | Chemistry; Metallurgy | 1 | Active |
| US11053238B2 | Benzimidazole derivatives, preparation methods and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11365196B2 | FGFR inhibitor and application thereof | Chemistry; Metallurgy | 1 | Active |
| US7629367B2 | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators | Chemistry; Metallurgy | 1 | Expired |
| US7402577B2 | Androstane 17-beta-carboxamides as androgen receptor modulators | Chemistry; Metallurgy | 0 | Expired |
| US10484272B2 | Packet forwarding in RPR network | Electricity | 0 | Active |
| US11466013B2 | ERK inhibitor and use thereof | Chemistry; Metallurgy | 0 | Active |
| US12187713B2 | Immunomodulators, compositions and methods thereof | Chemistry; Metallurgy | 0 | Active |
| US11845762B2 | Compound functioning as bromodomain protein inhibitor, and composition | Chemistry; Metallurgy | 0 | Active |
| US11466034B2 | Compound functioning as bromodomain protein inhibitor, and composition | Chemistry; Metallurgy | 0 | Active |
| US7625919B2 | 4-azasteroid derivatives as androgen receptor modulators | Chemistry; Metallurgy | 0 | Active |
| US9718806B2 | Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor | Chemistry; Metallurgy | 0 | Active |
| US7109191B2 | Benzazepinone alpha vintegrin receptor antagonists | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.